Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects
Metadatos
Mostrar el registro completo del ítemAutor
Rus Martínez, María del Alma; López-Sánchez, José Alberto; Martínez-Martos, José Manuel; Ramírez-Expósito, Mª Jesús; Molina, Francisco; Correa Rodríguez, María; Aguilar Ferrandiz, María EncarnaciónMateria
Amino Acid Fibromyalgia
Fecha
2023-10-16Referencia bibliográfica
Mol Diagn Ther. 2023 Oct 16. doi: 10.1007/s40291-023-00677-8.
Resumen
Background Fibromyalgia is a complex illness to diagnose and treat.
Objectives To evaluate a broad range of circulating free amino acid (AA) levels in fibromyalgia patients as well as the ability
of the AAs to differentiate fibromyalgia patients from healthy subjects.
Design We carried out a case-control study to evaluate AA levels in 62 patients with fibromyalgia and 78 healthy subjects.
This study adheres to the STROBE guidelines.
Methods AAs content was assayed by HPLC in serum samples. The predictive value of AA levels in fibromyalgia was
determined by receiver operating characteristic (ROC) curve and forward binary logistic regression analyses.
Results Fibromyalgia patients showed higher serum levels of aspartic acid, glutamic acid, aminoadipic acid, asparagine,
histidine, 3-methyl-histidine, 5-methyl-histidine, glycine, threonine, taurine, tyrosine, valine, methionine, isoleucine, phenylalanine,
leucine, ornithine, lysine, branched chain AAs (BCAAs), large neutral AAs, essential AAs (EAAs), non-essential
AAs (NEAAs), basic AAs, EAAs/NEAAs ratio, phenylalanine/tyrosine ratio, and global arginine bioavailability ratio than
the controls. Serum alanine levels were lower in patients than in controls. According to ROC analysis, most of these AAs may
be good markers for differentiating individuals with fibromyalgia from healthy subjects. Results of logistic regression showed
that the combination of glutamic acid, histidine, and alanine had the greatest predictive ability to diagnose fibromyalgia.
Conclusions Our results show an imbalance in serum levels of most AAs in patients with fibromyalgia, which suggest a
metabolic disturbance. The determination of serum levels of these AAs may aid in the diagnosis of fibromyalgia, in combination
with clinical data of the patient.